Care that evolves with your needs.
We offer psychiatric care, therapy, and advanced treatments — personalized to support your mental health journey.
Explore Spravato® Treatment at The Psychiatric Center
Spravato® (esketamine) is a prescription nasal spray approved for adults with treatment-resistant depression (TRD), a form of depression that has not improved after trying at least two different antidepressant medications. Spravato® offers a new approach for those who have not found relief with traditional treatments.
Dr. Sarah Graff is a REMS (Risk Evaluation and Mitigation Strategy) certified provider for Spravato® (esketamine) treatment. This certification is an important distinction that ensures patients receive Spravato® safely and in accordance with strict federal guidelines.
By choosing a REMS certified provider like Dr. Graff, patients can feel confident that their Spravato® treatment will be delivered with the utmost attention to safety, monitoring, and support throughout the process.
Discover the Benefits of Spravato® Treatment
Proven Symptom Relief
Experience faster improvement in depressive symptoms compared to traditional treatments.
Personalized Care Plans
Tailored treatment strategies designed to meet your unique mental health needs.
Expert Provider Guidance
Receive care from Dr. Sarah Graff MD, a certified Spravato® REMS provider committed to your well-being.
Safe and Monitored Administration
Benefit from treatments conducted in-office with careful monitoring for safety and support.
Understanding Spravato®
Discover the comprehensive treatment journey with Spravato® REMS, from eligibility evaluation to post-therapy care, guided by our expert team.
Step One: Consultation and Assessment
Begin with a thorough evaluation by Dr. Sarah Graff MD to determine if Spravato® is the right advanced therapy for your treatment-resistant depression.
Step Two: Treatment Sessions
Attend supervised Spravato® sessions at our office, where your response is carefully monitored to ensure safety and effectiveness. During each treatment, patients are monitored over the course of two hours.
Step Three: Ongoing Support
Complete the prescribed course and receive continued support to maintain improvements and address any concerns along your recovery path.